Brief international cognitive assessment for multiple sclerosis: screening for cognitive impairment

Takeaway

  • The Brief International Cognitive Assessment for Multiple Sclerosis is a good diagnostic tool for cognitive impairment in multiple sclerosis.

Why this matters

    Cognitive impairment affects up to 65% of people with multiple sclerosis. Although there are numerous neuropsychological batteries to evaluate cognitive function, most of them are time-consuming or require expertise that restricts their use to specialized multiple sclerosis centers. These important findings demonstrate that the Brief International Cognitive Assessment for Multiple Sclerosis is a good screening tool for cognitive impairment that can be used in everyday clinical practice.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.